ERIS LIFESCIENCES
Quarterly Results Analysis [Sep2024]
ERIS LIFESCIENCES Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹741 Cr | ₹720 Cr | ₹551 Cr | ₹486 Cr | ₹505 Cr | ₹467 Cr | ₹403 Cr | ₹423 Cr |
Expenses | ₹477 Cr | ₹470 Cr | ₹402 Cr | ₹311 Cr | ₹324 Cr | ₹297 Cr | ₹284 Cr | ₹286 Cr |
Operating Income | ₹265 Cr | ₹250 Cr | ₹148 Cr | ₹176 Cr | ₹181 Cr | ₹170 Cr | ₹119 Cr | ₹137 Cr |
Other Income | ₹5 Cr | ₹2 Cr | ₹15 Cr | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
Interest | ₹59 Cr | ₹60 Cr | ₹33 Cr | ₹18 Cr | ₹16 Cr | ₹17 Cr | ₹9 Cr | ₹3 Cr |
Depreciation | ₹80 Cr | ₹76 Cr | ₹54 Cr | ₹46 Cr | ₹42 Cr | ₹41 Cr | ₹35 Cr | ₹30 Cr |
Profit Before Tax | ₹129 Cr | ₹115 Cr | ₹77 Cr | ₹116 Cr | ₹126 Cr | ₹112 Cr | ₹76 Cr | ₹107 Cr |
Profit After Tax | ₹96 Cr | ₹89 Cr | ₹80 Cr | ₹101 Cr | ₹122 Cr | ₹94 Cr | ₹61 Cr | ₹100 Cr |
EPS | ₹6.73 | ₹6.11 | ₹5.22 | ₹7.55 | ₹9.08 | ₹6.98 | ₹4.81 | ₹7.49 |
Industry Peers & Returns | 1W | 1M | 1Y |
ERIS LIFESCIENCES | 8.2% | 15.1% | 57.8% |
SUN PHARMACEUTICAL INDUSTRIES | -0.9% | -4.8% | 50.2% |
CIPLA | 1.5% | 0.1% | 19.9% |
DR REDDYS LABORATORIES | -0.4% | -8.2% | 7.1% |
ZYDUS LIFESCIENCES | 0.6% | -5.3% | 51% |
DIVIS LABORATORIES | 3% | 5.9% | 65% |
MANKIND PHARMA | 0.6% | 3.1% | 34.4% |
TORRENT PHARMACEUTICALS | 4.3% | -2.7% | 54.2% |
LUPIN | -0.1% | -4.4% | 72.4% |
ERIS LIFESCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 2.98 % |
Y-o-Y | 46.68 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹741 Cr | 2.98 | |
Jun2024 | ₹720 Cr | 30.64 | |
Mar2024 | ₹551 Cr | 13.29 | |
Dec2023 | ₹486 Cr | -3.76 | |
Sep2023 | ₹505 Cr | 8.29 | |
Jun2023 | ₹467 Cr | 15.84 | |
Mar2023 | ₹403 Cr | -4.83 | |
Dec2022 | ₹423 Cr | - |
ERIS LIFESCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 5.81 % |
Y-o-Y | 46.03 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹265 Cr | 5.81 | |
Jun2024 | ₹250 Cr | 68.42 | |
Mar2024 | ₹148 Cr | -15.43 | |
Dec2023 | ₹176 Cr | -3.11 | |
Sep2023 | ₹181 Cr | 6.71 | |
Jun2023 | ₹170 Cr | 42.77 | |
Mar2023 | ₹119 Cr | -13.34 | |
Dec2022 | ₹137 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 2.76 % |
Y-o-Y | -0.45 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 35.69% | 2.76 | |
Jun2024 | 34.73% | 28.92 | |
Mar2024 | 26.94% | -25.35 | |
Dec2023 | 36.09% | 0.67 | |
Sep2023 | 35.85% | -1.46 | |
Jun2023 | 36.38% | 23.24 | |
Mar2023 | 29.52% | -8.95 | |
Dec2022 | 32.42% | - |
ERIS LIFESCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 7.75 % |
Y-o-Y | -21.22 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹96 Cr | 7.75 | |
Jun2024 | ₹89 Cr | 12.29 | |
Mar2024 | ₹80 Cr | -21.51 | |
Dec2023 | ₹101 Cr | -17.04 | |
Sep2023 | ₹122 Cr | 30.59 | |
Jun2023 | ₹94 Cr | 52.33 | |
Mar2023 | ₹61 Cr | -38.66 | |
Dec2022 | ₹100 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 4.67 % |
Y-o-Y | -46.28 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 13 % | 4.67 | |
Jun2024 | 12.42 % | -14.05 | |
Mar2024 | 14.45 % | -30.73 | |
Dec2023 | 20.86 % | -13.80 | |
Sep2023 | 24.2 % | 20.58 | |
Jun2023 | 20.07 % | 31.52 | |
Mar2023 | 15.26 % | -35.56 | |
Dec2022 | 23.68 % | - |
ERIS LIFESCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 10.15 % |
Y-o-Y | -25.88 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹6.73 | 10.15 | |
Jun2024 | ₹6.11 | 17.05 | |
Mar2024 | ₹5.22 | -30.86 | |
Dec2023 | ₹7.55 | -16.85 | |
Sep2023 | ₹9.08 | 30.09 | |
Jun2023 | ₹6.98 | 45.11 | |
Mar2023 | ₹4.81 | -35.78 | |
Dec2022 | ₹7.49 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD